ALMIRALL, S.A. «...161718» Page 17 out of 18 11/05/2020 07:36 ALMIRALL, S.A. Other relevant information Conference Call with analysts and Institutional investors Register number: 2150 11/05/2020 07:26 ALMIRALL, S.A. Interim management report La sociedad remite declaración intermedia de gestión del primer trimestre de 2020 Register number: 2149 06/05/2020 18:19 ALMIRALL, S.A. Liquidity and counterparty agreements Operaciones del contrato de liquidez durante el primer trimestre de 2020 Register number: 2074 24/03/2020 17:44 ALMIRALL, S.A. Announcement of general shareholders’ meeting Ordinary Shareholders Meeting Register number: 1166 09/03/2020 12:11 ALMIRALL, S.A. On business and financial situation Almirall announces FDA acceptance for filing of U.S. New Drug Application (NDA) for tirbanibulin in actinic keratosis Register number: 804 02/03/2020 08:45 ALMIRALL, S.A. On business and financial situation Almirall announces EMA acceptance for filing of Marketing Authorization Application (MAA) for tirbanibulin in actinic keratosis Register number: 680 24/02/2020 07:28 ALMIRALL, S.A. On corporate governance Otra Información Relevante sobre modificación del Reglamento Interno de Conducta en el Mercado de Valores de Almirall Register number: 198 24/02/2020 07:22 ALMIRALL, S.A. Announcement of general shareholders’ meeting Convocatória Junta General de Accionistas Register number: 197 24/02/2020 07:11 ALMIRALL, S.A. Annual corporate governance report La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2019 Register number: 195 24/02/2020 07:11 ALMIRALL, S.A. Annual report on directors´ remunerations La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del Ejercicio 2019 Register number: 194 Page 17 out of 18 «...161718»
